Signal from the log
Cellular Origins
40 M$ · Series A · United Kingdom · Biotech
Société de Cambridge, au Royaume-Uni, qui automatise par robotique la fabrication des thérapies cellulaires, en reliant entre elles les machines déjà présentes dans les laboratoires plutôt qu'en les remplaçant. L'enjeu est le coût de ces traitements, aujourd'hui produits presque à la main.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 40 M$
- Stage
- Series A
- Country
- United Kingdom
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Johnson & Johnson Innovation , with Highland Europe , BGF , NYBC Ventures , TTP Group
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.